ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 46 filers reported holding ARGOS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $23,000 | -50.0% | 129,046 | 0.0% | 0.00% | – |
| Q2 2017 | $46,000 | -35.2% | 129,046 | -18.2% | 0.00% | – |
| Q1 2017 | $71,000 | -90.5% | 157,707 | +3.0% | 0.00% | – |
| Q4 2016 | $750,000 | +1.9% | 153,065 | +3.3% | 0.00% | – |
| Q3 2016 | $736,000 | +29.6% | 148,230 | +59.9% | 0.00% | – |
| Q2 2016 | $568,000 | +82.1% | 92,713 | +89.8% | 0.00% | – |
| Q1 2016 | $312,000 | +200.0% | 48,851 | +7.9% | 0.00% | – |
| Q4 2015 | $104,000 | -52.5% | 45,292 | +0.3% | 0.00% | – |
| Q3 2015 | $219,000 | -28.9% | 45,170 | +0.3% | 0.00% | – |
| Q2 2015 | $308,000 | -23.0% | 45,048 | +0.1% | 0.00% | – |
| Q1 2015 | $400,000 | +5.3% | 44,987 | +18.2% | 0.00% | – |
| Q4 2014 | $380,000 | 0.0% | 38,050 | +0.5% | 0.00% | – |
| Q3 2014 | $380,000 | +128.9% | 37,867 | +82.2% | 0.00% | – |
| Q2 2014 | $166,000 | -29.7% | 20,784 | -12.1% | 0.00% | – |
| Q1 2014 | $236,000 | – | 23,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
| Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
| SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
| WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
| Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
| WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 157,707 | $71,000 | 0.00% |
| SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
| BlackRock Inc. | 795,101 | $360,000 | 0.00% |